Mobile colistin resistance (mcr), extended-spectrum beta-lactamase (esbl) and multidrug resistance monitoring in escherichia coli (commensal and pathogenic) in pig farming: need of harmonized guidelines and clinical breakpoints

HIGHLIGHTS

• who: ufeffVanesaufeff ufeffGarcu00edaufeff et al. from the The University of Tennessee, United States have published the research work: Mobile colistin resistance (MCR), extended-spectrum beta-lactamase (ESBL) and multidrug resistance monitoring in ufeffEscherichia coliufeff (commensal and pathogenic) in pig farming: need of harmonized guidelines and clinical breakpoints, in the Journal: LREC_294
• what: The aim of this alliance was to reduce the consumption of colistin to 5 mg/population correction unit (PCU) in 3 years and control the alternative consumption of neomycin and/or apramycin. The authors aimed to gain knowledge on the diagnosis and clinical . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.